Descriptor English: | Erythromycin Estolate | ||||||
Descriptor Spanish: |
Estolato de Eritromicina
| ||||||
Descriptor Portuguese: | Estolato de Eritromicina | ||||||
Descriptor French: | Érythromycine estolate | ||||||
Entry term(s): |
Eromycin Erythromycin Propionate Dodecyl Sulfate Erythromycin Propionate Lauryl Sulfate Erythromycin Propionate Monododecyl Sulfate Estolate, Erythromycin Ilosone Lauromicina |
||||||
Tree number(s): |
D02.540.576.500.992.250 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D004918 | ||||||
Scope note: | A macrolide antibiotic, produced by Streptomyces erythreus. It is the lauryl sulfate salt of the propionic ester of erythromycin. This erythromycin salt acts primarily as a bacteriostatic agent. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Anti-Bacterial Agents Enzyme Inhibitors Gastrointestinal Agents Protein Synthesis Inhibitors |
||||||
Registry Number: | XRJ2P631HP | ||||||
CAS Type 1 Name: | Erythromycin, 2'-propanoate, dodecyl sulfate (salt) | ||||||
Previous Indexing: |
Erythromycin (1970-1974) Propionates (1974) Sodium Dodecyl Sulfate (1974) |
||||||
Public MeSH Note: | 91; was see under ERYTHROMYCIN 1975-90 |
||||||
History Note: | 91(75); was see under ERYTHROMYCIN 1975-90 |
||||||
DeCS ID: | 28028 | ||||||
Unique ID: | D004918 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1991/01/01 | ||||||
Date of Entry: | 1974/11/19 | ||||||
Revision Date: | 2015/06/22 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals
|
Erythromycin Estolate
- Preferred
Ilosone
- Narrower
Lauromicina
- Narrower
Eromycin
- Narrower
Concept UI |
M0007723 |
Scope note | A macrolide antibiotic, produced by Streptomyces erythreus. It is the lauryl sulfate salt of the propionic ester of erythromycin. This erythromycin salt acts primarily as a bacteriostatic agent. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. |
Preferred term | Erythromycin Estolate |
Entry term(s) |
Erythromycin Propionate Dodecyl Sulfate Erythromycin Propionate Lauryl Sulfate Erythromycin Propionate Monododecyl Sulfate Estolate, Erythromycin |
Concept UI |
M0352018 |
Preferred term | Ilosone |
Concept UI |
M0352017 |
Preferred term | Lauromicina |
Concept UI |
M0352019 |
Preferred term | Eromycin |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey